Invitrogen™ ELISA Kit CD55 / Human DAF

Ref.: BL-RE-093685Manufacturer ref.: EH93RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

CD55 (acceleration factor of decay, DAF) is a membrane glycoprotein anchored by GPI that protects autologous cells from the classical and alternative path of the complement cascade. Two-way interactions between...

Accession number
P08174
Dose range
0.85 to 200 ng/ml
Sensitivity of the dosage
0.85 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

CD55 (acceleration factor of decay, DAF) is a membrane glycoprotein anchored by GPI that protects autologous cells from the classical and alternative path of the complement cascade. Two-way interactions between...

CD55 (acceleration factor of decay, DAF) is a membrane glycoprotein anchored by GPI that protects autologous cells from the classical and alternative path of the complement cascade. Two-way interactions between CD55 and CD97 are involved in T cell regulation and CD55 can regulate the complement when it is bound to CD97. In tumours, CD55 promotes neoangiogenesis, tumourigenesis, invasiveness and avoidance of apoptosis. CD55 is a 70 kDa glycoprotein (in erythrocytes) anchored to the membrane by the glycosylphosphatidylinositol tail. In other cells, the apparent molecular weight is slightly greater for CD55s and has a substantial O-glycan content. The CD55 binds to C4b or C3b complement fragments activated on the cell surface, preventing assembly and accelerating the degradation of conventional and alternative pathways. CD55 carries antigens from blood groups associated with Cromer. Two alternative CD55-encrypted cross-transcripts were identified and the predominant encoded crosstranscript was a membrane-bound protein expressed on plasma-exposed cells, but an alternative-spinned transcription produced a soluble protein at much lower levels. CD55 was studied to play a role in the growth and survival of prostate cancer.

Sensitivity

Sensitivity of dosage: 0.85 ng/ml.

Measurement range

Dose range: 0.85 to 200 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: CD55.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17717863
Specifications
Accession numberP08174
Dose range0.85 to 200 ng/ml
Sensitivity of the dosage0.85 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)1604
Gene symbol(s)CD55
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetCD55
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 μl-Plasma, 50 μl-Surnatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH93RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.